PHIO
#4661
Phio Pharmaceuticals Corp. - Common Stock
0.9 4 USD
+0.02%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+2.17%
Variación mensual
-8.74%
Variación en los últimos 6 meses
-22.95%
Cambio anual
-21.01%
Cierres anteriores
0.9 2
Open
0.9 6
Mínimo
0.9 2
Máximo
0.9 6
Financials
- Market Capitalization 10.92 M
- Employee 6
- Founded 2011
- CEO N/A
- Website www.phiopharma.com
- Headquarter Delaware, United States
- FIGI BBG0024FKD97
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.72
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4656 |  ENSC Ensysce Biosciences, Inc. - Common Stock | 0.61 USD | +8.93% | +41.86% | +24.49% | +59.48% | 11.87 M USD | ||
| 4658 |  INTS Intensity Therapeutics, Inc. - Common Stock | 3.12 USD | -5.74% | -12.11% | -21.21% | +940.00% | 10.19 M USD | ||
| 4662 |  TOVX Theriva Biologics, Inc. Common Stock | 0.22 USD | -4.35% | -8.33% | -8.33% | -11.15% | 10.10 M USD | ||
| 4668 |  VTGN Vistagen Therapeutics, Inc. - Common Stock | 0.21 USD | -8.70% | -19.23% | -16.00% | -59.23% | 9.32 M USD |